Project Cure CRC
The Alliance is on a mission to end colorectal cancer. With Project Cure CRC, we’re funding research to make it happen.
Project Cure CRC addresses an urgent need
Colorectal cancer claims more than 50,000 lives annually in the U.S., with a 13% survival rate for metastatic disease. Despite rising cases in young adults, research funding lags behind, threatening to make CRC the deadliest cancer under 50 by 2030.
Our plan to find cures
We initiated Project Cure CRC to make a difference in outcomes for the millions of people affected by this disease, and we are committed to working with experts, industry, and donors to achieve that goal.
A $100 million commitment
Project Cure CRC is making available tens of millions of dollars to innovators whose work aims to expedite colorectal cancer research to a curable science.
Innovation is in progress
Project Cure CRC has already invested millions of dollars into promising high-risk/high-reward research.
Seeking visionaries
Ending colorectal cancer will take broad collaboration. The Alliance seeks supporters and researchers to advance Project Cure CRC.
Up Next
The breakthrough fundTop resources
Alliance Presents Project Cure CRC Posters at AACR & Awards New Grants
Project Cure CRC funds cutting-edge colorectal cancer (CRC) research and aims to improve patient outcomes through its dynamic patient navigation portal, BlueHQ.org.
Alliance Survey Reveals Disparities in Minorities that Could Increase Colorectal Cancer Risk
Minority groups are significantly less aware that colorectal cancer is often not detected until the late stages due to mild symptoms.
NIH: Combination immunotherapy shrank GI cancers
A new kind of tumor infiltrating lymphocyte (TIL) therapy improved the treatment’s effectiveness in patients with metastatic GI cancers.